LBA45 Overall survival (OS) outcomes from NRG-GY004, a phase III study comparing single-agent olaparib or combination cediranib and olaparib to platinum (Plat) based chemotherapy in recurrent plat sensitive ovarian cancer (OvCa)

J.F. Liu; M. Brady; U.A. Matulonis; A. Miller; E.C. Kohn; E. Swisher; W. Tew; N. Cloven; C. Muller; D. Bender; R. Moore; D. Michelin; S. Waggoner; M. Geller; K. Fujiwara; S. D'Andre; M. Carney; A.A. Secord; J. Walker; M.A. Bookman

doi:10.1016/j.annonc.2023.10.039

Back

LBA45 Overall survival (OS) outcomes from NRG-GY004, a phase III study comparing single-agent olaparib or combination cediranib and olaparib to platinum (Plat) based chemotherapy in recurrent plat sensitive ovarian cancer (OvCa)

Abstract

Peer reviewed

LBA45 Overall survival (OS) outcomes from NRG-GY004, a phase III study comparing single-agent olaparib or combination cediranib and olaparib to platinum (Plat) based chemotherapy in recurrent plat sensitive ovarian cancer (OvCa)

J.F. Liu, M. Brady, U.A. Matulonis, A. Miller, E.C. Kohn, E. Swisher, W. Tew, N. Cloven, C. Muller, D. Bender, …

Annals of oncology, Vol.34(Suppl. 2), pp.S1285-S1285

10/2023

DOI: 10.1016/j.annonc.2023.10.039

View Online

Details

Title: Subtitle: LBA45 Overall survival (OS) outcomes from NRG-GY004, a phase III study comparing single-agent olaparib or combination cediranib and olaparib to platinum (Plat) based chemotherapy in recurrent plat sensitive ovarian cancer (OvCa)
Creators: J.F. Liu - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
M. Brady - Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
U.A. Matulonis - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
A. Miller - Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
E.C. Kohn - CTEP, National Cancer Institute, Bethesda, MD, USA
E. Swisher - University of Washington
W. Tew - Memorial Sloan Kettering Cancer Center
N. Cloven - Department of Gynecologic Oncology, Texas Oncology, Fort Worth, TX, USA
C. Muller - University of New Mexico
D. Bender - University of Iowa
R. Moore - University of Rochester Medical Center
D. Michelin - Obstetrics & Gynecology Department, Cancer Research Consortium of West Michigan, Grand Rapids, MI, USA
S. Waggoner - Case Western Reserve University
M. Geller - University of Minnesota
K. Fujiwara - Saitama Medical University
S. D'Andre - Sutter Institute for Medical Research
M. Carney - University of Hawaii System
A.A. Secord - Duke University
J. Walker - University of Oklahoma Health Sciences Center
M.A. Bookman - Kaiser Permanente
Resource Type: Abstract
Publication Details: Annals of oncology, Vol.34(Suppl. 2), pp.S1285-S1285
DOI: 10.1016/j.annonc.2023.10.039
ISSN: 0923-7534
eISSN: 1569-8041
Publisher: Elsevier Ltd
Language: English
Date published: 10/2023
Academic Unit: Obstetrics and Gynecology
Record Identifier: 9984500080502771

Metrics

10 Record Views

4 Times Cited - Web of Science

See more details